Search Results 101-110 of 17919 for Crohns disease

1. Patients with Inflammatory Bowel Disease Have Higher Risk of Melanoma - Mayo Clinic News Network

   Mayo Clinic researchers found that IBD is associated with a 37 percent greater risk for the disease. More than 1.5 million Americans have Crohn's disease or ...

2. A Study to Assess the Efficacy and Safety of Risankizumab in Subjects With Moderately to Severely Active Crohn's Disease Who Failed Prior Biologic Treatment - Mayo Clinic

   A Study to Assess the Efficacy and Safety of Risankizumab in Subjects With Moderately to Severely Active Crohn's Disease Who Failed Prior Biologic Treatment.

3. A Study to Evaluate the Safety and Efficacy of Ustekinumab Induction Therapy in Patients with Moderately to Severely Active Crohn's Disease (UNITI-2) - Mayo Clinic

   Have active Crohn's disease, defined as a baseline Crohn Disease Activity Index (CDAI) score of ≥ 220 and ≤ 450, with confirmation of active inflammation ...

4. Efficacy and Safety Study of Mongersen (GED-0301) for the Treatment of Subjects With Active Crohn's Disease - Mayo Clinic

   About this study. The purpose of study is to test the effects of an experimental medication GED-0301 (mongersen) in patients who have active Crohn's disease ...

5. Stem Cell Fistula Plug in Perianal Crohn's Disease - Mayo Clinic

   Twenty adult patients (age 18 years or older) with refractory, complicated perianal fistulizing Crohn's disease will be enrolled. Subjects will undergo ...

6. Adverse effects related to Heplisav-B vaccination in patients with Inflammatory Bowel Disease - Mayo Clinic

   ... Crohn's disease. It is now the standard of practice vaccine that we use in ... IBD and chronic liver disease. In this study, we aim to collect data on ...

7. A Study of Vedolizumab in Children and Teenagers With Moderate to Severe Crohn's Disease (CD) - Mayo Clinic

   A Study of Vedolizumab in Children and Teenagers With Moderate to Severe Crohn's Disease (CD) · Overview · Participation eligibility · Participating Mayo Clinic ...

8. An Extension Study Monitoring the Safety of Patients with Crohn's Disease Previously Enrolled in the Etrolizumab Phase III Study GA29144 - Mayo Clinic

   Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines ...

9. Pediatric MSC-AFP Sub-study for Crohn's Fistula - Mayo Clinic

   ... Crohn's disease. Autologous means these cells to coat the plug come from the patient. Participation eligibility. Participant eligibility includes age, gender ...

10. Treatment response and management of biologics in patients with ECD - Mayo Clinic

    Esophageal Crohn's disease (ECD) is a rare, aggressive form of inflammatory bowel disease (IBD). Patients with ECD often present with inflammation, ...